Jie Wang XianYe Cheng Yan Lu BingRong Zhou
10.2147/DDDT.S168248
Drug Des Devel Ther
2018 Jul 11;12:2163-2167.
azd-9291 egfr-tkis nsclc ten osimertinib
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/30034220/
Acrylamides / adverse effects Aniline Compounds / adverse effects Antineoplastic Agents / adverse effects Carcinoma, Non-Small-Cell Lung / drug therapy ErbB Receptors / antagonists & inhibitors Lung Neoplasms / drug therapy Protein Kinase Inhibitors / adverse effects Stevens-Johnson Syndrome / drug therapy
Acrylamides / adverse effects Aniline Compounds / adverse effects Antineoplastic Agents / adverse effects Carcinoma, Non-Small-Cell Lung / drug therapy ErbB Receptors / antagonists & inhibitors Lung Neoplasms / drug therapy Protein Kinase Inhibitors / adverse effects Stevens-Johnson Syndrome / drug therapy Case Reports Acrylamides / administration & dosage Acrylamides / pharmacology Aniline Compounds / administration & dosage Aniline Compounds / pharmacology Antineoplastic Agents / administration & dosage Antineoplastic Agents / pharmacology Carcinoma, Non-Small-Cell Lung / diagnosis Carcinoma, Non-Small-Cell Lung / pathology Dose-Response Relationship, Drug ErbB Receptors / metabolism Humans Lung Neoplasms / diagnosis Lung Neoplasms / pathology Male Middle Aged Protein Kinase Inhibitors / administration & dosage Protein Kinase Inhibitors / pharmacology Stevens-Johnson Syndrome / diagnosis Stevens-Johnson Syndrome / pathology Acrylamides Aniline Compounds Antineoplastic Agents Protein Kinase Inhibitors osimertinib ErbB Receptors
PMC6047856
30034220
A case report of toxic epidermal necrolysis associated with AZD-9291
2018